Literature DB >> 27012381

Genomic and Epigenomic Landscape in Meningioma.

Wenya Linda Bi1, Yu Mei2, Pankaj K Agarwalla3, Rameen Beroukhim3, Ian F Dunn4.   

Abstract

Meningiomas are the most common primary intracranial neoplasms in adults. Despite their prevalence, their biologic underpinnings remain incompletely described. The recent application of unbiased next-generation sequencing and epigenomic approaches has implicated a new array of candidate biomarkers and oncogenic drivers. These insights may serve to craft a molecular taxonomy for meningiomas and highlight putative therapeutic targets in an era of biology-informed precision medicine.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epigenetics; Genomics; Meningioma; Molecular taxonomy; Precision medicine

Mesh:

Year:  2016        PMID: 27012381     DOI: 10.1016/j.nec.2015.11.009

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  5 in total

1.  Recurrent meningioma of the scalp after 13 years.

Authors:  Daniel Lee Ashmore; Rachel Clancy; Paul D Chumas
Journal:  BMJ Case Rep       Date:  2016-07-07

2.  Genetic variants and increased risk of meningioma: an updated meta-analysis.

Authors:  Xiao-Yong Han; Wei Wang; Lei-Lei Wang; Xi-Rui Wang; Gang Li
Journal:  Onco Targets Ther       Date:  2017-03-28       Impact factor: 4.147

Review 3.  Identification and Management of Aggressive Meningiomas.

Authors:  Bhuvic Patel; Rupen Desai; Sangami Pugazenthi; Omar H Butt; Jiayi Huang; Albert H Kim
Journal:  Front Oncol       Date:  2022-03-23       Impact factor: 6.244

4.  The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous system.

Authors:  Derek Wong; Yaoqing Shen; Adrian B Levine; Erin Pleasance; Martin Jones; Karen Mungall; Brian Thiessen; Brian Toyota; Janessa Laskin; Steven J M Jones; Marco A Marra; Stephen Yip
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-08-01

Review 5.  The Current State of Radiomics for Meningiomas: Promises and Challenges.

Authors:  Hao Gu; Xu Zhang; Paolo di Russo; Xiaochun Zhao; Tao Xu
Journal:  Front Oncol       Date:  2020-10-27       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.